<DOC>
	<DOCNO>NCT00480506</DOCNO>
	<brief_summary>The purpose study collect peripheral blood bone marrow aspirate sample thalassemia patient Tehran , collaborative effort develop erythroid lineage specific chimerism assay applicable patient thalassemia . Development assay would useful identification exact mutation cause disease , well provide direct method measure monitor kinetics donor erythropoiesis patient population follow transplant .</brief_summary>
	<brief_title>Monitoring Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation Thalassemia Major</brief_title>
	<detailed_description>- In first phase study develop panel reagent design identify predominant thalassemia mutation Iranian population , well alternative highly variable erythroid specific polymorphism . To determine informative panel , reagent apply sample collect patient homozygous disorder , compare patient thalassemia trait normal Iranian donor . - In second phase , propose serially measure compare erythroid lineage chimerism overall genomic chimerism follow transplant . Samples collect participant 1 , 2 , 3 , 6 12 month follow transplant cryopreserved . Peripheral blood stem cell donor also collect cryopreserved . Participants undergo myeloablative nonmyeloablative transplant .</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<criteria>Thalassemia patient treat Shariati Hospital Tehran .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>chimerism</keyword>
	<keyword>allogenic hematopoietic transplantation</keyword>
	<keyword>assay</keyword>
</DOC>